Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryClaus Vogelmeier, Àlvar Agustí|American Journal of Respiratory and Critical Care Medicine|2017Cited by 3.2k
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya P. Bhatt, Raolat M. Abdulai, Klaus F. Rabe et al.|New England Journal of Medicine|2023Cited by 452
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialHenrik Watz, Peter M.A. Calverley, Kay Tetzlaff et al.|The Lancet Respiratory Medicine|2016Cited by 420
Benralizumab for the Prevention of COPD ExacerbationsGerard J. Criner, Ubaldo J. Martin, Claus Vogelmeier et al.|New England Journal of Medicine|2019Cited by 329
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 InflammationSurya P. Bhatt, Lacey B. Robinson, Klaus F. Rabe et al.|New England Journal of Medicine|2024Cited by 240